Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
Standard Lancets Market contains market size and forecasts of Standard Lancets in global, including the following market information:
- Global Standard Lancets Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Standard Lancets Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Standard Lancets companies in 2021 (%)
The global Standard Lancets market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Needle Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Standard Lancets include Roche, Lifescan, BD, Bayer, Abbott, B. Braun, ARKRAY, Terumo and I-SENS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Standard Lancets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Standard Lancets Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Standard Lancets Market Segment Percentages, by Type, 2021 (%)
Global Standard Lancets Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Standard Lancets Market Segment Percentages, by Application, 2021 (%)
- Hospitals and Clinics
- Homecare Settings
- Others
Global Standard Lancets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Standard Lancets Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Standard Lancets revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Standard Lancets revenues share in global market, 2021 (%)
- Key companies Standard Lancets sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Standard Lancets sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche
- Lifescan
- BD
- Bayer
- Abbott
- B. Braun
- ARKRAY
- Terumo
- I-SENS
- Nipro
- Omron
- Infopia
- AgaMatrix
- Smiths Medical
- Sarstedt
- SANNUO
- Yicheng
- Yuwell
- Greiner Bio One
- Edan
- Narang Medical
Industry Market Size
